Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9FM5

PvSub1 Catalytic Domain in Complex with Peptidomimetic Inhibitor (AL-97)

9FM5 の概要
エントリーDOI10.2210/pdb9fm5/pdb
分子名称subtilisin, 5,6-DIHYDRO-BENZO[H]CINNOLIN-3-YLAMINE, CALCIUM ION, ... (6 entities in total)
機能のキーワードsubtilisin, alpha-ketoamides, sar, hydrolase, cell invasion
由来する生物種Plasmodium vivax (malaria parasite P. vivax)
詳細
タンパク質・核酸の鎖数4
化学式量合計142459.77
構造登録者
Batista, F.A.,Martinez, M.,Bouillon, A.,Mechaly, A.,Alzari, P.M.,Haouz, A.,Barale, J.C. (登録日: 2024-06-05, 公開日: 2025-02-05, 最終更新日: 2025-04-30)
主引用文献Puszko, A.K.,Batista, F.A.,Ejjoummany, A.,Bouillon, A.,Maurel, M.,Adler, P.,Legru, A.,Martinez, M.,Ortega Varga, L.,Hadjadj, M.,Alzari, P.M.,Blondel, A.,Haouz, A.,Barale, J.C.,Hernandez, J.F.
Towards Improved Peptidic alpha-Ketoamide Inhibitors of the Plasmodial Subtilisin-Like SUB1: Exploration of N-Terminal Extensions and Cyclic Constraints.
Chemmedchem, 20:e202400924-e202400924, 2025
Cited by
PubMed Abstract: After more than 15 years of decline, the Malaria epidemy has increased again since 2017, reinforcing the need to identify drug candidates active on new targets involved in at least two biological stages of the Plasmodium life cycle. The SUB1 protease, which is essential for parasite egress in both hepatic and blood stages, would meet these criteria. We previously reported the structure-activity relationship analysis of α-ketoamide-containing inhibitors encompassing positions P4-P2'. Despite compounds with high inhibitory potencies were identified, their antiparasitic activity remained limited, probably due to insufficient cell permeability. Here, we present our efforts to improve it through the N-terminal introduction of basic or hydrophobic moieties and/or cyclization. Compared to our previous reference compounds 1/2 (Ac-Ile/Cpg-Thr-Ala-AlaCO-Asp-Glu(Oall)-NH2), we identified analogues with improved Pf-/PvSUB1 inhibition (IC50 values in the 10-20 nM  range) and parasite growth inhibition (up to 98% at 100 μM). The increase in potency was mainly observed when increasing the overall hydrophobicity of the compounds. Conjugation to the cell penetrating peptide octa-arginine was also favorable. Finally, the crystal structure of PvSUB1 in complex with compound 15 has been determined at 1.6 Å resolution. Compared to compound 1, this structure extended to the P5 residue and revealed two additional hydrogen bonds.
PubMed: 39832214
DOI: 10.1002/cmdc.202400924
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.597 Å)
構造検証レポート
Validation report summary of 9fm5
検証レポート(詳細版)ダウンロードをダウンロード

238895

件を2025-07-16に公開中

PDB statisticsPDBj update infoContact PDBjnumon